Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Medical Equipment Industry Analysis

UpdatedApr 05, 2026
DataAggregated Company Financials
Companies12
  • 7D1.0%
  • 3M-1.9%
  • 1Y13.8%
  • YTDn/a

Over the last 7 days, the Medical Equipment industry has risen 1.0%, driven by gains from Smith & Nephew of 1.2%. This takes the industry's 12 month performance to a gain of 14%. Earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the U.K. Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 05 Apr 2026UK£10.8bUK£4.9bUK£442.5m21.8x24.5x2.2x
Tue, 03 Mar 2026UK£12.2bUK£4.6bUK£334.7m23.4x36.6x2.6x
Thu, 29 Jan 2026UK£11.0bUK£4.5bUK£326.8m26.4x33.7x2.4x
Sat, 27 Dec 2025UK£10.9bUK£4.6bUK£334.4m19.2x32.6x2.4x
Mon, 24 Nov 2025UK£11.2bUK£4.8bUK£337.8m22.2x33.1x2.4x
Wed, 22 Oct 2025UK£12.1bUK£4.7bUK£330.3m21.1x36.6x2.6x
Fri, 19 Sep 2025UK£12.5bUK£4.6bUK£276.2m32.6x45.3x2.7x
Sun, 17 Aug 2025UK£12.4bUK£4.6bUK£277.6m32.4x44.7x2.7x
Tue, 15 Jul 2025UK£10.5bUK£4.5bUK£221.8m31.9x47.3x2.3x
Thu, 12 Jun 2025UK£10.5bUK£4.5bUK£219.6m32.2x47.8x2.3x
Sat, 10 May 2025UK£10.0bUK£4.6bUK£235.2m30.2x42.3x2.2x
Mon, 07 Apr 2025UK£9.6bUK£4.7bUK£246.3m28.1x39.1x2.1x
Wed, 05 Mar 2025UK£10.9bUK£4.7bUK£255.9m24x42.7x2.3x
Fri, 31 Jan 2025UK£9.6bUK£4.7bUK£175.2m23.8x54.9x2x
Sun, 29 Dec 2024UK£9.3bUK£4.7bUK£173.1m26x53.6x2x
Tue, 26 Nov 2024UK£9.3bUK£4.7bUK£173.3m24x53.5x2x
Thu, 24 Oct 2024UK£10.5bUK£4.5bUK£166.9m25.6x63x2.3x
Sat, 21 Sep 2024UK£10.8bUK£4.4bUK£162.1m29.3x66.7x2.4x
Mon, 19 Aug 2024UK£11.0bUK£4.5bUK£162.9m43.2x67.4x2.4x
Wed, 17 Jul 2024UK£10.1bUK£4.5bUK£129.8m45.7x77.9x2.3x
Fri, 14 Jun 2024UK£9.5bUK£4.5bUK£142.7m42.8x66.9x2.1x
Sun, 12 May 2024UK£9.5bUK£4.6bUK£138.1m41.7x68.5x2.1x
Tue, 09 Apr 2024UK£8.8bUK£4.5bUK£127.1m46.9x69.4x1.9x
Thu, 07 Mar 2024UK£9.8bUK£4.5bUK£111.2m45.4x88.1x2.2x
Sat, 03 Feb 2024UK£10.1bUK£4.4bUK£31.3m55.4x322.4x2.3x
Mon, 01 Jan 2024UK£9.9bUK£4.4bUK£29.9m54.9x332.1x2.3x
Wed, 29 Nov 2023UK£9.4bUK£4.4bUK£30.3m51.9x309.3x2.1x
Fri, 27 Oct 2023UK£8.4bUK£4.6bUK£37.4m43.9x224.3x1.8x
Sun, 24 Sep 2023UK£9.6bUK£4.6bUK£38.3m81.1x250x2.1x
Tue, 22 Aug 2023UK£9.9bUK£4.4bUK£33.4m60.1x295.7x2.2x
Thu, 20 Jul 2023UK£11.0bUK£4.2bUK£37.7m60.2x291.2x2.6x
Sat, 17 Jun 2023UK£11.5bUK£4.3bUK£39.3m77.7x293.9x2.7x
Mon, 15 May 2023UK£11.7bUK£4.4bUK£42.5m68.9x275.2x2.7x
Wed, 12 Apr 2023UK£10.8bUK£4.4bUK£28.1m57.2x386.5x2.5x
Price to Earnings Ratio

386.5x


Total Market Cap: UK£10.8bTotal Earnings: UK£28.1mTotal Revenue: UK£4.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Medical Equipment Industry Price to Earnings3Y Average 124.1x202420252026
Current Industry PE
  • Investors are pessimistic on the British Healthcare Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.5x which is lower than its 3-year average PE of 124x.
  • The industry is trading close to its 3-year average PS ratio of 2.3x.
Past Earnings Growth
  • The earnings for companies in the Healthcare Equipment industry have grown 151% per year over the last three years.
  • Revenues for these companies have grown 3.6% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.K. Medical Equipment compare with similar industries?

GB Market4.54%
Healthcare5.69%
Medical Equipment0.98%
Medical Equipment1.00%
Medical Supplies0.93%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SN. Smith & NephewUK£12.081.2%
+UK£172.5m		17.2%PE21.8x
AOTI AOTIUK£0.357.6%
+UK£2.7m		-58.2%PE18.7x

Latest News

CLBX
UK£0.009
CelLBxHealth
7D
-5.3%
1Y
-90.0%

CLBX: Cost Discipline And Refocused Regulatory Approach Will Support Future Oncology Upside

Analysts have kept their fair value estimate for CelLBxHealth steady at £0.07 per share, with a slightly higher discount rate and a small adjustment to long term profit margin and future P/E assumptions guiding this latest price target update. What's in the News CelLBxHealth decided to discontinue maintenance of its FDA establishment license and device listing for the Parsortix system, aligning its regulatory approach with current operational and commercial priorities while focusing on cost discipline (Key Developments).
SN.
UK£12.08
Smith & Nephew
7D
1.2%
1Y
17.2%

SN.: New Product Launches And Capital Returns Will Support Future Margins

Analysts have nudged their price target for Smith & Nephew slightly higher to £14.30 from £14.30, reflecting small adjustments to their fair value estimate, discount rate, revenue growth assumptions, profit margin expectations, and a modestly lower future P/E multiple. What's in the News Launch of ALLEVYN COMPLETE CARE Foam Dressing with a five layer design aimed at both wound management and pressure injury prevention, initially in the US with further international launches planned for 2026 (Product related announcement).
AOTI
UK£0.35
AOTI
7D
7.6%
1Y
-58.2%

Broader CMS Coverage And Home Care Trends Will Reshape This Chronic Wound Therapy Business

Catalysts About AOTI AOTI provides topical wound oxygen therapy and at home care services aimed at healing hard to heal chronic wounds. What are the underlying business or industry changes driving this perspective?
NIOX
UK£0.55
NIOX Group
7D
-4.8%
1Y
-23.3%
EKF
UK£0.23
EKF Diagnostics Holdings
7D
-0.8%
1Y
8.8%
CREO
UK£0.11
Creo Medical Group
7D
-8.4%
1Y
-9.4%

CREO: Steady Fair Value And Higher Revenue Assumptions Will Support Long Term Upside

Analysts have made a modest upward adjustment to their price target for Creo Medical Group, reflecting fine tuned assumptions around the discount rate, revenue growth and future P/E. Their view of the company’s fair value remains broadly unchanged.
OBI
UK£0.10
Ondine Biomedical
7D
-2.3%
1Y
13.5%
IHC
UK£0.21
Inspiration Healthcare Group
7D
-1.8%
1Y
27.8%
EMVC
UK£0.52
EMV Capital
7D
-1.0%
1Y
30.4%
TECH
UK£0.0035
TechFinancials
7D
-12.5%
1Y
75.0%